THC:CBD In Daily Practice: Available Data From UK, Germany And Spain

Multiple Sclerosis (MS)

Key Findings

The homogeneity between these observational studies supports the interest in THC:CBD oromucosal spray for management of MS spasticity in daily practice.

Information and Links


Link: THC:CBD In Daily Practice: Available Data From UK, Germany And Spain

Year: 2016


Ratings

(How Ratings Work)

Multiple Sclerosis (MS) — 3


Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.

Drugs Used

Sativex (THC:CBD) oromucosal spray